Propolis Versus Calcium Hydroxide on Post-Operative Pain in Patients With Necrotic Pulp

Sponsor
Cairo University (Other)
Overall Status
Completed
CT.gov ID
NCT04983524
Collaborator
(none)
46
2
31

Study Details

Study Description

Brief Summary

Propolis is a resinous product of honeybees. Propolis is said to be effective against resistant microorganisms inside the root canal compared to the gold standard medication known as calcium hydroxide. The clinical trial tests the effect of propolis versus calcium hydroxide on pain in patients with necrotic teeth.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: propolis
  • Drug: Calcium Hydroxide
N/A

Detailed Description

Propolis is an immunomodulatory, antioxidant, flavonoid-rich resinous product of honeybees. Propolis was reported as less cytotoxic and more effective against resistant microorganisms than calcium hydroxide as well as biocompatible to the periradicular tissues than existing intracanal medicaments. The aim of this single-blinded randomized clinical trial was to evaluate the effect of propolis versus calcium hydroxide, intracanal medicaments, on post-operative pain in patients with necrotic single canal teeth. Methods: Forty-six participants with an age range of 20-40 years old, diagnosed as having necrotic pulp in their single-rooted, single canal teeth were included in this study, with 23 participants in each group. Treatment was done in two visits and intracanal medicament was applied for one week in between. Participants were instructed to rate their pain score by a numerical rating scale after 24, 48, 72 hours and at 7 days.

Study Design

Study Type:
Interventional
Actual Enrollment :
46 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Diagnostic
Official Title:
Evaluation of the Effect of Propolis Versus Calcium Hydroxide, Intracanal Medicaments on Post-Operative Pain in Patients With Necrotic Pulp (A Randomized Clinical Trial)
Actual Study Start Date :
Oct 1, 2015
Actual Primary Completion Date :
May 1, 2018
Actual Study Completion Date :
May 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Propolis

intervention intracanal medicament

Dietary Supplement: propolis
resinous product of honeybees

Active Comparator: Calcium Hudroxide

Gold standard intracanal medicament

Drug: Calcium Hydroxide
Gold standard control intracanal medicament

Outcome Measures

Primary Outcome Measures

  1. post-operative pain [one week. line of 10 points]

    Categorical data on numerical rating scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 40 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • • Asymptomatic patients with age range 20 - 40 years

  • Necrotic, single canal maxillary and mandibular teeth with periapical infection presented as radiolucency or widening in the periodontal membrane space.

  • Medically - free of any systemic disease

  • Teeth with complete root formation

Exclusion Criteria:
  • • Pregnant or lactating females

  • Teeth with vital pulps, internal or external resorption or anatomic abnormalities

  • Teeth with cracks, curvatures, root caries and calcified canals

  • Double or triple-rooted teeth

  • Patients with facial swelling, acute pulpal or periapical lesion

  • Teeth that are not indicated for endodontic treatment: Bad oral hygiene, mobile or recessed

  • Previously endodontically-treated teeth

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Cairo University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Serene Mohamed Hisham Sirry, Principle Investigator, Cairo University
ClinicalTrials.gov Identifier:
NCT04983524
Other Study ID Numbers:
  • SSirry
First Posted:
Jul 30, 2021
Last Update Posted:
Jul 30, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Serene Mohamed Hisham Sirry, Principle Investigator, Cairo University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 30, 2021